Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 29, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Hepatic Encephalopathy
Interventions
DRUG

AXA1665

AXA1665 administered TID with food

DRUG

Placebo

Matching placebo administered TID with food

Trial Locations (40)

10016

New York University (NYU) School of Medicine, New York

10021

Weill Medical College of Cornell University, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

21202

Mercy Medical Center, Baltimore

22903

University of Virginia School of Medicine, Charlottesville

23114

Virginia Commonwealth University, Richmond

23249

McGuire Research Institute, Inc., McGuire VA Medical Center, Richmond

23602

Bon Secours Liver Institute, Newport News

28222

Hospital Universitario Puerta de Hierro, Majadahonda

28304

Cumberland Research Associates, Fayetteville

29425

Medical University of South Carolina (MUSC), Charleston

32610

UF Hepatology Research at CTRB, Gainesville

32713

OMEGA Research Consultants, DeBary

33032

Homestead Associates in Research, Miami

33100

Azienda sanitaria universitaria Friuli Centrale (ASU FC), Udine

33136

University of Miami, Miami

46202

Indiana University School of Medicine, Indianapolis

52242

University of Iowa, Iowa City

75246

Baylor Scott & White Research Institute, Fort Worth

77030

Advanced Liver Therapies at St. Luke's Episcopal Hospital, Houston

78229

Pinnacle Clinical Research, San Antonio

78359

Optimed Research, Edinburg

80131

Azienda Ospedaliera Universitaria Federico II, Naples

94143

University of California, San Francisco (UCSF), San Francisco

T2N 4Z6

University of Calgary, Calgary

N6A 2C2

LMC Diabetes & Endocrinology Ltd. - London, London

Unknown

The Ottawa Hospital, Ottawa

Debreceni Egyetem Klinikai Kozpont, Debrecen

Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, Székesfehérvár

KO - MED Centra Kliniczne Lublin II, Lublin

ID Clinic, Mysłowice

SONOMED Sp. z o.o., Szczecin

Prywatna Specjalistyczna Praktyka Lekarska Jan Gietka, Warsaw

Centrum Badan Klinicznych Piotr Napora Lekarze Sp. p., Wroclaw

Corporacio Sanitaria Parc Tauli - Hospital de Sabadell, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Hospital Universitario Marques de Valdecilla, Santander

Hospital Clinico Universitario de Santiago, Santiago de Compostela

Hospital Universitario Virgen del Rocio, Seville

The Royal Infirmary of Edinburgh, Edinburgh

Sponsors
All Listed Sponsors
lead

Axcella Health, Inc

INDUSTRY

NCT04816916 - Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter